Andrea Newkirk

Stock Analyst at Goldman Sachs

(0.51)

# 4,073

Out of 4,969 analysts

3

Total ratings

n/a

Success rate

-1.25%

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - Specialty & Generic

Stocks Rated by Andrea Newkirk

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ALKS Alkermes	Initiates: Buy	$43	$30.00	+43.33%	1	Jul 15, 2025
	RVMD Revolution Medicines	Initiates: Buy	$65	$39.77	+63.44%	1	Jul 15, 2025
	ETNB 89bio	Initiates: Neutral	$11	$9.24	+19.05%	1	Mar 14, 2025

Alkermes

Jul 15, 2025

Initiates: Buy

Price Target: $43

Current: $30.00

Upside: +43.33%

Revolution Medicines

Jul 15, 2025

Initiates: Buy

Price Target: $65

Current: $39.77

Upside: +63.44%

89bio

Mar 14, 2025

Initiates: Neutral

Price Target: $11

Current: $9.24

Upside: +19.05%